Evidence map›Paper›PMID 41275293›Full record

ArticleRespiratory research2025

The P4HA1/HIF1α feedback loop modulates endothelial dysfunction in pulmonary hypertension.

Yunwei Chen, Yifei Lv, Meng Yang, Zhiyuan Qian, Xiaomin Jiang, Zihao Jiang, Chaohua Kong, Yue Gu, Yunfei Deng, Shao-Liang Chen

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yunwei ChenDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yifei LvDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Meng YangDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zhiyuan QianDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Xiaomin JiangDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zihao JiangDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Chaohua KongDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yue GuDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. guyue_jessica@163.com.
Yunfei DengDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. dengyunfei_1988@126.com.
Shao-Liang ChenDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. chmengx@126.com.

Funding

China Postdoctoral Science Foundation 2022M711665Jiangsu Innovative and Entrepreneurial Talent Program JSSCBS20211539National Natural Science Foundation of China 82170350National Natural Science Foundation of China 82300071Natural Science Foundation of Jiangsu Province BK20210030
6 · The paper itself

Abstract

backgroundPulmonary hypertension is a severe vascular disease characterised by pulmonary arterial remodeling and right heart failure. However, the role of the glycolytic protein P4HA1 in its pathogenesis remains elusive.

methodsRNA-seq analysis was performed on hypoxic human pulmonary artery endothelial cells, and P4HA1 expression was validated in PH animal models. In vitro, P4HA1 knockdown was used to assess its effects on glycolysis, proliferation, and migration. Mechanistic studies included HIF1α transcriptional regulation and P4HA1-mediated HIF1α stabilization via reduced ubiquitination. AAV9-shP4HA1 was employed to assess P4HA1's function in pulmonary vascular remodeling in vivo.

resultsP4HA1 was significantly upregulated in human pulmonary arterial endothelial cells (HPAECs) exposed to hypoxia. Mechanistic investigations revealed that HIF1α transcriptionally activates P4HA1 expression, while P4HA1 reciprocally stabilizes HIF1α by attenuating its ubiquitin-mediated degradation, thereby establishing a self-amplifying signaling loop. Functional studies demonstrated that P4HA1 knockdown effectively suppressed hypoxia-induced glycolytic reprogramming, inhibited cellular proliferation, and impaired migratory capacity in HPAECs. Consistent with these in vitro findings, endothelial-specific P4HA1 knockdown in vivo significantly attenuated hypoxia-induced pulmonary vascular remodeling and improved right ventricular function in a mouse PH model.

conclusionsOur studty identify P4HA1 as a novel contributor to PH pathogenesis and suggest that targeting the P4HA1/HIF1α axis may offer a promising therapeutic approach for pulmonary hypertension.

Indexed as

Endothelial CellsEndothelium, VascularFeedback, PhysiologicalHypertension, PulmonaryHypoxia-Inducible Factor 1, alpha SubunitAnimalsCells, CulturedDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLProcollagen-Proline DioxygenasePulmonary ArteryVascular RemodelingHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitP4HA1 protein, humanProcollagen-Proline DioxygenaseEndothelial cellsGlycolysisHIF1αP4HA1Pulmonary hypertension

Identifiers

PMID41275293
PMCPMC12751831

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.